Patents
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
06/1999
06/23/1999EP0923529A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
06/23/1999EP0923528A1 Oligosaccharide synthesis
06/23/1999CN1220656A Novel trienoic retinoid compounds and method
06/22/1999US5914429 Industrial process for the continuous preparation of sodium orthohydroxymandelate
06/17/1999WO1999029651A1 Sodium (s)-2-(6-methoxy-2-naphthyl)-propionate monohydrate
06/17/1999WO1999029640A2 Compositions and methods for modulating the activity of fibroblast growth factor
06/17/1999DE19753817A1 Production of acrolein and acrylic acid by catalytic oxidation of propane
06/16/1999CN1219931A Process for making phenyl heterocycles useful as COX-2 inhibitors
06/16/1999CN1219389A Apoptosis inhibitor
06/15/1999US5912371 Chlorinating unsaturated fatty acid silylation product; haloacylation
06/15/1999US5911992 Suppress appetite, and also acts to induce thermogenesis and inhibit lipogenesis, so as to prevent weight gain, st. john's wort,
06/10/1999WO1999000512B1 Method for conversion of biomass to chemicals and fuels
06/09/1999EP0736001B1 Aryl acetic acid derivatives and their use as fungicides
06/08/1999US5910606 Process for making α,β-unsaturated carboxylic acids
06/08/1999US5910508 Novel compounds useful in modulating cellular hormone receptors; treating skin disorders such as acne, psoriasis
06/03/1999WO1999026902A1 A solid-phase technology for the preparation of combinatorial libraries through amide-bond anchoring
06/03/1999CA2311490A1 A solid-phase technology for the preparation of combinatorial libraries through amide-bond anchoring
06/02/1999CN1043529C Carbonylation of epoxides
06/01/1999CA2142314C Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol
05/1999
05/20/1999DE19751200A1 New epothilone derivatives
05/20/1999DE19751046A1 Production of acrolein and acrylic acid by catalytic oxidation of propane
05/19/1999EP0915846A2 2- and 2,5-substituted phenylketoenols
05/19/1999EP0915823A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/19/1999EP0915822A1 Process for preparing perfluoro-[2-(n-propoxyl)-propionyl]fluoride
05/19/1999EP0915819A1 Illudin analogs useful as antitumor agents
05/18/1999CA2109744C 1-phenylbicyclo¬2.2.2|octane derivatives, a process for their preparation and pharmaceutical compositions holding same
05/14/1999WO1999007692A3 New epothilone derivatives, method for producing same and their pharmaceutical use
05/12/1999EP0915080A1 Process for preparing optically active amines and optically active carboxylic acids, and intermediates for preparation
05/12/1999EP0914315A1 Stable, non-hygroscopic salts of l(-)carnitine and alkanoyl l(-)carnitines, a process for their preparation and solid, orally administrable compositions containing such salts
05/12/1999EP0914130A2 Novel anti-viral compounds
05/12/1999EP0686139B1 Alkaline calcium/zinc mixed soaps
05/12/1999CN1216522A Therapeutic agent for diabetes
05/12/1999CN1216460A Oxa diacids and related compounds for treating skin conditions
05/11/1999US5902783 Particles having core comprising peroxy compound, coating containing alkali metal silicate and aliphatic acid chelating agent; storage stability
05/11/1999CA2028818C Production of alpha-(3-benzoylphenyl)-propionic acid derivative
05/06/1999WO1999021823A1 Optically active intermediates for the preparation of optically active substituted oximes, hydrazones and olefins useful as neurokinin antagonists
05/06/1999EP0912531A1 Polyoxyalkene substituted and bridged triazine, benzotriazole and benzophenone derivatives as uv absorbers
05/06/1999EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds
05/06/1999EP0912487A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
05/06/1999EP0912479A1 Process for the manufacture of oxygenates
05/06/1999EP0801637B1 Process for improving the purity of hexane diol-1,6
05/06/1999DE19749717A1 New epothilone derivatives
05/06/1999CA2308073A1 Optically active intermediates for the preparation of optically active substituted oximes, hydrazones and olefins useful as neurokinin antagonists
05/04/1999US5900496 Hydroxylation; rearrangement in presence of soluble enzymerecovered from culture
05/04/1999US5900221 Process of preparing a solution of cesium and rubidium salts
04/1999
04/29/1999WO1999020590A1 Method of heterogeneous catalyzed vapor-phase oxidation of propane to acrolein and/or acrylic acid
04/29/1999DE19748928A1 New epothilone derivatives
04/29/1999DE19746667A1 Heterogeneous catalyzed gas phase oxidation of propane to acrolein and acrylic acid
04/28/1999EP0911321A2 Compounds for the treatment of osteoporosis
04/28/1999EP0911314A1 Apoptosis inhibitor
04/28/1999EP0910561A1 Inhibitors of oleamide hydrolase
04/28/1999EP0910331A1 Oxa diacids and related compounds for treating skin conditions
04/28/1999CN1215390A Substituted phenyl keto enols as pesticides and herbicides
04/27/1999US5897995 Combination of glucose oxidase and catalase enzymes
04/22/1999WO1999019313A1 Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
04/22/1999WO1999019291A1 Biphenyl-5-alkanoic acid derivatives and use thereof
04/22/1999WO1999019290A2 Lactic acid processing; methods; arrangements; and, products
04/22/1999WO1999019289A1 Recovery and recycle of catalyst components used in palladium-catalyzed preparation of arylcarboxylic acids
04/22/1999WO1999018947A1 Process to make chiral compounds
04/22/1999DE19746210A1 Production of acrolein and acrylic acid by heterogeneous catalyzed gas phase oxidation of propane
04/22/1999CA2306768A1 Process to make chiral compounds
04/22/1999CA2306425A1 Recovery and recycle of catalyst components used in palladium-catalyzed preparation of arylcarboxylic acids
04/21/1999EP0909754A1 Process to make chiral compounds
04/14/1999EP0907632A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
04/10/1999CA2249867A1 Osteoporosis compounds
04/08/1999WO1999016770A1 Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic
04/07/1999EP0906901A2 Process for producing propionic acid derivatives
04/07/1999EP0906900A1 A process for preparing optically active 2-hydroxy-methyl-3-phenylpropionic acid
04/07/1999EP0906300A1 Process for making phenyl heterocycles useful as cox-2 inhibitors
04/07/1999EP0906264A1 Process for the production of alkaline metal salts and earth alkali metal salts of aryloxy-c1-c4-alkaline carboxylic
04/06/1999US5892098 Inhibit activity of phosphodiesterase iv and production of tumor necrosis factor; treating asthma
04/01/1999WO1999000512A3 Method for conversion of biomass to chemicals and fuels
04/01/1999WO1998054329A9 Production of medium chain length poly-3-hydroxy alkanoates in escherichia coli, and monomers derived therefrom
03/1999
03/31/1999EP0904260A1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids
03/31/1999EP0742788B1 Process for the preparation of a linear formyl compound
03/30/1999US5889107 Hydrosol of complex salt of group 4 metal with organic alpha-hydroxy and/or alpha-oxo acid, comprising surface active substance
03/25/1999WO1999014210A1 Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
03/25/1999WO1999014180A1 Method for preparing light-coloured ether carboxylic acids
03/24/1999EP0903332A1 Process for preparing substituted phenylpropenen
03/23/1999US5886193 Coupling to a support carriers
03/23/1999US5886043 Antiarthritic agents, antitumor agents, antiinflammatory agents
03/23/1999US5886024 Thiophene-containing butonic acid derivatives as matrix metalloprotease inhibitors
03/23/1999US5886022 Treatment of osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis bullosa
03/18/1999WO1999012919A1 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
03/18/1999WO1999012898A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
03/18/1999WO1999012885A1 Substituted alkenoic acids and their derivatives
03/17/1999EP0902007A1 Chalcone derivatives and drugs containing the same
03/17/1999EP0902002A1 New derivatives of phthalaldehyde, process for their preparation and their use
03/17/1999EP0626954B1 Benzocycloheptenes, benzoxepines and benzothiepines
03/16/1999US5883294 Selective thyroid hormone analogs
03/16/1999US5883267 Process for making phenyl heterocycles useful as cox-2 inhibitors
03/16/1999US5883248 Quaternary ammonium intermediates
03/16/1999US5883235 Calix 4!arene compounds for detection of calcium
03/12/1999CA2246928A1 Novel phthalaldehyde derivatives, process for their preparation, and their use
03/11/1999WO1999011596A1 Agricultural or horticultural preparation with light stability
03/11/1999WO1999011256A1 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
03/11/1999WO1999011255A1 Peroxisome proliferator-activated receptor controllers
03/11/1999WO1998057910A3 Cyclooxygenase-i selective inhibitors and the use thereof as analgesic, antiinflammatory and antiarthritic agents
03/11/1999DE19829097A1 Substituierte Alkensäuren und ihre Derivate Substituted alkenoic and their derivatives
03/10/1999EP0900190A1 Novel acetals of hydroxy carboxylic acids, derivatives thereof and process for the preparation thereof
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 147